martes, 18 de junio de 2019

Pfizer spends $11.4B to buy Array BioPharma for its cancer drug chemistry

Pfizer spends $11.4B to buy Array BioPharma for its cancer drug chemistry

Cancer Briefing

Pfizer spends $11.4 billion to buy Array BioPharma for its cancer drug chemistry

By MATTHEW HERPER


RUBY WALLAU FOR STAT
Targeted cancer drugs such as the ones that Array develops have been a major part of Pfizer’s research over the past decade.

No hay comentarios: